Does Mounjaro Lower Blood Sugar?
Yes, Mounjaro lowers blood sugar. Its active ingredient, tirzepatide, activates two gut hormones that increase insulin release and reduce glucagon. Clinical trials show it can reduce HbA1c by up to 2.1 percentage points. On its own, it carries a low risk of causing hypoglycaemia. That risk rises when combined with insulin or sulfonylureas.
Table of Contents
What Is Mounjaro, and What Is It Used For?
Mounjaro is a prescription-only weekly injection containing tirzepatide as its active ingredient. It belongs to a class of medicines called dual GIP and GLP-1 receptor agonists.
In the UK, it is licensed for two purposes. It manages blood sugar in adults with type 2 diabetes, and it supports weight loss in adults who meet specific clinical criteria. This article focuses on how it affects blood sugar.
Tirzepatide is the first medicine to activate both the GIP and GLP-1 receptors at the same time. That dual action is what sets it apart from older single-receptor drugs like semaglutide.
How Does Mounjaro Lower Blood Sugar?
Mounjaro works through several linked mechanisms. Each one plays a distinct role in keeping blood sugar under control.
GIP Receptor Activation
GIP stands for glucose-dependent insulinotropic polypeptide. It is a hormone your gut releases when you eat. Tirzepatide mimics this hormone and tells the pancreas to produce more insulin when blood sugar rises after a meal.
GLP-1 Receptor Activation
GLP-1 (glucagon-like peptide-1) is a second gut hormone. Activating GLP-1 receptors further stimulates insulin secretion in response to food. This is the same pathway used by semaglutide, but tirzepatide adds the GIP layer on top, making it more potent overall.
Reduced Glucagon Production
Glucagon signals the liver to release stored glucose into the bloodstream. Tirzepatide suppresses glucagon secretion, which keeps that extra glucose release in check. In people with type 2 diabetes, glucagon is often overactive, so this suppression matters.
Slower Gastric Emptying
Mounjaro slows how quickly food passes from your stomach into your small intestine. This blunts the sharp post-meal blood sugar spike. It also keeps you feeling fuller for longer, which reduces overall food intake and the amount of glucose entering your system.
Together, these mechanisms produce steady and meaningful blood sugar control throughout the day.
How Much Can Mounjaro Lower Blood Sugar?
The clinical evidence is strong. The SURPASS trial programme studied tirzepatide across thousands of people with type 2 diabetes and produced clear data on blood sugar outcomes.
HbA1c Reductions
HbA1c reflects your average blood sugar over roughly three months. In SURPASS-2, tirzepatide reduced HbA1c by 2.01% at 5 mg, 2.24% at 10 mg, and 2.30% at 15 mg. That outperformed semaglutide, which produced a 1.86% reduction in the same trial.
In SURPASS-1, which studied tirzepatide as a standalone therapy, the 15 mg dose reduced HbA1c by 2.58 percentage points from baseline. That is a substantial result for a single medicine.
Fasting Blood Sugar
Fasting glucose levels also fell considerably. The 15 mg dose reduced fasting serum glucose by roughly 3.9 mmol/L compared to placebo across SURPASS trials. For most adults with type 2 diabetes, the fasting glucose target is below 7.0 mmol/L.
Post-Meal Glucose
Because Mounjaro slows gastric emptying, the spike in blood sugar after eating is noticeably reduced. Studies across all dose strengths showed meaningful improvements in two-hour post-meal glucose readings.
Does Dosage Strength Make a Difference?
Yes. The 10 mg and 15 mg doses consistently produce better blood sugar outcomes than the 5 mg starting dose. Though, treatment begins at 2.5 mg once weekly for four weeks to help your body adjust, then increases to 5 mg. The dose can be stepped up further in 2.5 mg increments, with 5, 10, and 15 mg as the maintenance options.
Individual results vary. Baseline HbA1c, how long you have had diabetes, and kidney function all affect how much blood sugar reduction you see.
How Quickly Does Mounjaro Start Lowering Blood Sugar?
Mounjaro begins working from the first dose. That said, the full effect builds over weeks and months as doses increase.
First Week
Tirzepatide starts acting almost immediately after the first injection. Your body produces more insulin after meals and releases less glucagon. Some people notice improved blood sugar readings within the first few days.
First Month
By weeks two to four, slower gastric emptying and reduced appetite compound the effect. Post-meal spikes tend to be noticeably lower. Fasting glucose often begins to fall during this period too.
After Several Months
The most meaningful HbA1c improvements emerge between weeks 8 and 24. Most participants in clinical trials reached their target HbA1c between weeks 12 and 16 on a stable therapeutic dose. Reaching that stable dose takes time because of the step-up schedule.
Long-Term Management
Mounjaro is not a short-term course. Trial data at 52 and 104 weeks shows it maintains blood sugar control consistently when used on an ongoing basis. If you stop the medication, blood sugar levels typically return toward their previous levels over weeks to months.
Results vary between individuals. Always discuss your personal blood sugar targets with your prescriber or pharmacist.
How Mounjaro Can Cause Low Blood Sugar
Low blood sugar, known as hypoglycaemia, occurs when blood glucose falls below 4.0 mmol/L. It can happen with any medicine that affects blood sugar regulation, and Mounjaro is no exception. The risk, however, depends heavily on your individual situation.
Who Is Most at Risk?
When taken alone, Mounjaro carries a very low hypoglycaemia risk, under 2% in clinical studies. The picture changes significantly when it is combined with other diabetes medicines.
People who take Mounjaro alongside insulin or sulfonylureas face around a 10% risk of hypoglycaemia. Sulfonylureas include medicines like gliclazide and glipizide, which are commonly prescribed for type 2 diabetes. These drugs stimulate insulin release regardless of blood sugar level, which is why the combination raises risk.
Symptoms to Recognise
Hypoglycaemia can come on quickly. Common symptoms include sweating, shaking, dizziness, headache, sudden hunger, confusion, and a fast or irregular heartbeat. Some people also feel unusually irritable or anxious.
If these symptoms appear, check your blood sugar with your monitor if you have one. Treat it straight away with fast-acting carbohydrate, such as glucose tablets or a small glass of fruit juice.
Prevention and Monitoring
If you are on insulin or a sulfonylurea, your prescriber should review your doses before starting Mounjaro. Insulin doses in particular may need to be reduced. Regular blood sugar monitoring is especially important during the first few weeks of combined treatment.
Always carry fast-acting glucose with you, particularly if you drive. If low blood sugar episodes are happening often, speak to your pharmacist or GP without delay.
Frequently Asked Questions
Can Mounjaro lower blood sugar in people without diabetes?
Yes, it can. Tirzepatide acts on insulin and glucagon pathways regardless of your diabetes status. Studies show modest reductions in fasting glucose and HbA1c in people with prediabetes or obesity who do not have type 2 diabetes. The effect is less pronounced than in people with established diabetes, because their baseline blood sugar is already higher.
Does Mounjaro help with blood sugar levels overnight?
It can contribute to lower overnight blood sugar. Tirzepatide suppresses glucagon, which reduces the liver’s release of glucose while you sleep. But, if you also take insulin, the combination may increase your risk of nocturnal hypoglycaemia. Raise this with your prescriber if it concerns you.
Will my blood sugar go back up if I stop Mounjaro?
In most cases, yes. The blood sugar-lowering effect is tied to tirzepatide being active in your system. Once you stop, blood sugar typically returns toward previous levels over weeks to months. This is why Mounjaro is considered an ongoing treatment rather than a course you complete.
Can Mounjaro be used alongside metformin?
Yes, it frequently is. Mounjaro and metformin work through different mechanisms and can be used together. Whether other diabetes tablets can be reduced or stopped depends on your blood sugar control and should be decided by your prescriber, not changed on your own.
Is Mounjaro safe if I have had hypoglycaemia in the past?
Previous hypoglycaemia episodes do not automatically rule out Mounjaro. You should tell your prescriber and pharmacist about any history of low blood sugar, particularly if episodes have been severe. They may monitor you more closely, especially if you are also taking insulin or a sulfonylurea.
Does diet affect how well Mounjaro controls blood sugar?
Yes, significantly. A diet high in refined carbohydrates produces larger blood sugar spikes, even with Mounjaro. Reducing processed sugars and white starches makes the medication work more effectively. Your pharmacist or a diabetes dietitian can advise on practical changes specific to your diet.
Can Mounjaro prevent type 2 diabetes in people with prediabetes?
This is an active area of research. Some studies suggest tirzepatide may delay or prevent progression from prediabetes to type 2 diabetes by improving insulin sensitivity and reducing body weight. It is not currently licensed in the UK specifically for prediabetes, but your GP may consider it in certain clinical situations.
Conclusion
Mounjaro is one of the most effective medicines available for lowering blood sugar in type 2 diabetes. Its dual action on GIP and GLP-1 receptors reduces HbA1c, lowers fasting glucose, and blunts post-meal spikes. Clinical trials show reductions of up to 2.1 percentage points in HbA1c, which outperforms most other medicines in its class.
The risk of hypoglycaemia is low when Mounjaro is taken on its own. That risk rises meaningfully if you also take insulin or a sulfonylurea, so careful monitoring and dose adjustments are essential during the first few months of treatment.
If you want to know whether Mounjaro is suitable for managing your blood sugar, speak to one of our pharmacists today. We can review your current medicines, assess your suitability, and support you throughout your treatment safely.
Zainab Master is the Superintendent Pharmacist and owner of Your Local Pharmacy. With extensive experience in community pharmacy and patient care, she is dedicated to helping local patients access safe, professional, and convenient healthcare services. Zainab specialises in pharmacy-led treatments, travel vaccinations, earwax removal, contraception services, blood pressure checks, and everyday health advice. Her focus is on providing trusted healthcare support with a patient-first approach.